πŸ‡ΊπŸ‡Έ FDA
Patent

US 9175264

Postnatal stem cells and uses thereof

granted A61KA61K35/12A61K35/30

Quick answer

US patent 9175264 (Postnatal stem cells and uses thereof) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K35/12, A61K35/30, A61K47/02, A61P